Inflammatory bowel disease (IBD), encompassing Crohn's and Ulcerative Colitis, subtly manifests in infants through feeding ...

Scientists identify the complex interplay between immune dysfunction, genetics, environment and disease progression driving ...

The exclusive IBD Center is a first-of-its-kind integrated facility in the region, aimed at being a one-stop solution for IBD patients from across India ...

Growth has surged for road construction firm Construction Partners. Several heavy construction plays are just below buy ...

In this interview, Dr Ryan Stidham discusses the various ways in which artificial intelligence is being used to streamline ...

AN IRISH athletic therapist has revealed how he lived for years in chronic pain while being dismissed, before finally ...

AROUND 50,000 Irish people suffer with inflammatory bowel disease — but due to the nature of the condition, very few are open ...

A novel targeted drug delivery system could help improve the efficacy of medicines for inflammatory bowel disease (IBD) by ...

Ahead of World IBD Day, Crohn’s and Colitis Ireland have published a new conversation guide to aid better understanding of ...

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

The study shows how this new mechanism of disease, which is overactive in the intestine during inflammation, is able to control mucosal self-renewal, particularly in inflammatory bowel disease.